AstraZeneca signs strategic partnership with Beijing; invests $2.5bn

UK and Swedish pharmaceutical giant AstraZeneca is investing $2.5 billion in Beijing to establish its sixth global strategic research & development (R&D) centre, according to a March 21 announcement.



¬ Haymarket Media Limited. All rights reserved.

  

Read More

Leave a Reply